


Generic Drug Product Development. Bioequivalence. International Regulatory Requirements
Shargel, L. — Kanfer, I.
1ª Edición Febrero 2010
Inglés
400 pags
1200 gr
x x cm
ISBN 9780849377853
Editorial Informa Healthcare
Recíbelo en un plazo De 2 a 3 semanas
Generic Drug Product Development: Bioequivalence - International Regulatory Requirements discusses worldwide legislative and regulatory requirements for the registration of generic and/or multi-source drug products. An essential text for all professional involved in the regulation, development, and manufacture of brand-name or generic drugs, this guide provides expert advice on how to develop and market superior products while also successfully adhering to national and international laws.
Key topics include:
• how to choose the most appropriate reference drug product for generic and multi-source drugs
• the similarities and differences between US, European, and Asian legislative and regulatory requirements
• the importance of matching the quality and therapeutic equivalence of generic drugs manufactured domestically or imported to the brand product alternative
Key topics include:
• how to choose the most appropriate reference drug product for generic and multi-source drugs
• the similarities and differences between US, European, and Asian legislative and regulatory requirements
• the importance of matching the quality and therapeutic equivalence of generic drugs manufactured domestically or imported to the brand product alternative
Tel91 593 99 99
Fax91 448 21 88
DirC / Raimundo Lulio, 1, 28010 Madrid, España.
Mailpedidosweb@axon.esPrivacidadCondiciones de ventaQuiénes SomosAvisoContacto© 2021 Axón Librería S.L.
v1.53.0